Drug Type Small molecule drug |
Synonyms ONO-6950 |
Target |
Action antagonists |
Mechanism CysLT1 antagonists(Cysteinyl leukotriene receptor 1 antagonists), CysLT2 antagonists(cysteinyl leukotriene receptor 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC36H37F2NO5 |
InChIKeySILHYVDKGHXGBL-UHFFFAOYSA-N |
CAS Registry1232861-58-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Phase 2 | United States | 01 Mar 2012 | |
| Asthma, Exercise-Induced | Phase 2 | United States | 01 Mar 2012 |





